Literature DB >> 10903008

Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones.

K J van Erpecum1, N G Venneman, P Portincasa, G P Vanberge-Henegouwen.   

Abstract

Various agents may either enhance or impair post-prandial gall-bladder motility, and they are identified in this review. When studying the impact of medication on gall-bladder motility, the effects on interdigestive gall-bladder and intestinal motility should also be taken into account. Patients at high risk of gallstone disease, and patients who are treated chronically with gall-bladder motility inhibiting drugs, may benefit from improved gall-bladder motility using a prokinetic agent. However, there are no long-term studies to prove that such a strategy prevents gallstone formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903008     DOI: 10.1046/j.1365-2036.2000.014s2066.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

1.  Early changes in postprandial gallbladder emptying in morbidly obese patients undergoing Roux-en-Y gastric bypass: correlation with the occurrence of biliary sludge and gallstones.

Authors:  Michel Bastouly; Carlos Haruo Arasaki; Jael Brasil Ferreira; Arnaldo Zanoto; Fabíola Gouveia H P Borges; José Carlos Del Grande
Journal:  Obes Surg       Date:  2008-08-12       Impact factor: 4.129

Review 2.  Smooth muscle function and dysfunction in gallbladder disease.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gerard P vanBerge-Henegouwen
Journal:  Curr Gastroenterol Rep       Date:  2004-04

Review 3.  Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review.

Authors:  Sreedevi Koppisetti; Bharat Jenigiri; M Pilar Terron; Sandra Tengattini; Hiroshi Tamura; Luis J Flores; Dun-Xian Tan; Russel J Reiter
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

4.  Tiny cystine stones in the gallbladder of a patient with cholecystolithiasis complicating acute cholecystitis: a case report.

Authors:  Tie Qiao; Rui-Hong Ma; Xiao-Bing Luo; Yu-Yang Feng; Xing-Qiang Wang; Pei-Ming Zheng; Zhen-Liang Luo
Journal:  Eur J Med Res       Date:  2012-03-29       Impact factor: 2.175

5.  Gallbladder Stone Disease Is Associated with an Increased Risk of Migraines.

Authors:  Chien-Hua Chen; Cheng-Li Lin; Chia-Hung Kao
Journal:  J Clin Med       Date:  2018-11-21       Impact factor: 4.241

Review 6.  Research progress on the immune microenvironment of the gallbladder in patients with cholesterol gallstones.

Authors:  Jing-Yi Jiao; Xiao-Jun Zhu; Chun Zhou; Peng Wang
Journal:  World J Gastrointest Surg       Date:  2022-09-27

7.  Telocytes: new insight into the pathogenesis of gallstone disease.

Authors:  Andrzej Matyja; Krzysztof Gil; Artur Pasternak; Krystyna Sztefko; Mariusz Gajda; Krzysztof A Tomaszewski; Maciej Matyja; Jerzy A Walocha; Jan Kulig; Piotr Thor
Journal:  J Cell Mol Med       Date:  2013-04-04       Impact factor: 5.310

Review 8.  The mechanism of enterohepatic circulation in the formation of gallstone disease.

Authors:  Jian-Shan Cai; Jin-Hong Chen
Journal:  J Membr Biol       Date:  2014-08-09       Impact factor: 1.843

Review 9.  Recent advances in understanding and managing cholesterol gallstones.

Authors:  Agostino Di Ciaula; Piero Portincasa
Journal:  F1000Res       Date:  2018-09-24

10.  A Whole-Food-Based Health Product (A-F Betafood®) Improves Gallbladder Function in Humans at Risk of Gallbladder Insufficiency: A Randomized, Placebo-Controlled Clinical Trial.

Authors:  Malkanthi Evans; Najla Guthrie; Bassem F El-Khodor; Brandon Metzger; Saradhadevi Varadharaj
Journal:  Nutrients       Date:  2020-02-20       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.